Skip to main content
. 2022 Dec 28;2(3):106–111. doi: 10.1016/j.cjcpc.2022.12.004

Figure 1.

Figure 1

Patient survey responses and indications for ablation therapy. The survey response rate was 27.5%, and only complete responses were analysed. Substrate for supraventricular tachycardia listed as “Other” included empiric AV node modification and Mahaim pathway. AT, atrial tachycardia; AVNRT, atrioventricular nodal re-entry tachycardia; AVRT, atrioventricular re-entrant tachycardia; WPW, Wolff-Parkinson-White.